EGFR and neoplasm: To evaluate whether increased TGF-β and PGE2 production by EGFR inhibitor is detected in a broad range of epithelial tumors or just restricted to the SCC cell line Sa-3, we evaluated these cytokine production in several tumor cell lines pretreated with EGFR TKI.